Back to search

Syracuse University

Peptide Corrination for the Mitigation of Nausea and Emesis in the Treatment of Type 2 Diabetes

Abstract

dc:description.abstract

<p>This thesis addresses several questions focused on the activation of receptors expressed withinthe area postrema (AP) and the nucleus tractus solitarius (NTS), regions known to influence nausea and emesis. Prevention of such effects were achieved via corrination, covalent attachment to vitamin B12 (B12) or other corrin constructs, of GLP glucagon-like peptide-one (GLP-1) receptor (GLP-1R) agonists or via the use of GRASP a growth differentiation factor 15 (GDF15) glial derived neurotropic family receptor α-like (GFRAL) complex antagonist.</p>

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy (PhD)
Level thesis:degree_level
Dissertation
Discipline thesis:degree_discipline
Chemistry
Year
2021

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Tinsley, Ian
Contributors dc:contributor
  • Doyle, Robert P.

Subjects

dc:subject × 2

Identifiers

dc:identifier.*
Repository record dc:identifier
https://surface.syr.edu/etd/1432
OAI identifier oai:identifier
oai:surface.syr.edu:etd-2433

Chain of custody

source
Harvested from
Syracuse University
Base URL
surface.syr.edu/do/oai/
Last updated
2026-07-24
Source record
OAI-PMH GetRecord
citation

Tinsley, Ian. Peptide Corrination for the Mitigation of Nausea and Emesis in the Treatment of Type 2 Diabetes. Dissertation thesis, 2021. https://surface.syr.edu/etd/1432